Загрузка...
Impact of disease‐modifying drugs on the severity of COVID‐19 infection in multiple sclerosis patients
Recent evidence suggested that neurological manifestations occur in patients with a severe form of coronavirus disease (COVID‐19). On the basis of this issue, neurologists are very concerned about patients with neurological disorders, especially multiple sclerosis (MS), as consumers of immunosuppres...
Сохранить в:
| Опубликовано в: : | J Med Virol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675642/ https://ncbi.nlm.nih.gov/pubmed/33044760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26593 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|